<it>KRAS </it>rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study

<p>Abstract</p> <p>Background</p> <p>A single nucleotide polymorphism located in the 3'-untranslated region of the <it>KRAS </it>oncogene (<it>KRAS </it>variant; rs61764370) disrupts a let-7 miRNA binding and was recently reported to act as...

Full description

Bibliographic Details
Main Authors: Cerne Jasmina-Ziva, Stegel Vida, Gersak Ksenija, Novakovic Srdjan
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/12/105